Predictive Tool for Early Neurological Deterioration in Acute Minor Vertebrobasilar Occlusive Stroke Managed Medically.

IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY
Baolin Du, Wei Li, Jingwen Sun, Yeteng Zhang, Jun Hong
{"title":"Predictive Tool for Early Neurological Deterioration in Acute Minor Vertebrobasilar Occlusive Stroke Managed Medically.","authors":"Baolin Du, Wei Li, Jingwen Sun, Yeteng Zhang, Jun Hong","doi":"10.1016/j.wneu.2025.124304","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>We sought to construct a scoring model to predict early neurological worsening (END) among minor vertebrobasilar occlusive strokes (National Institutes of Health Stroke Scale [NIHSS] score < 6) following best medical management (BMM).</p><p><strong>Methods: </strong>Between January 2019 and June 2024, 137 patients were recruited from a single center. END was characterized by a ≥ 4-point rise in NIHSS within 72 hours, without intracranial hemorrhage. Logistic regression analysis identified predictors for END, which were used to construct a scale. External validation was performed using a separate cohort from another hospital during the same study period (n=81). Model performance was assessed using receiver operating characteristic (ROC) curve analysis, area under the curve (AUC), calibration plots, and Brier score.</p><p><strong>Results: </strong>END occurred in 41 patients (29.9%). Independent predictors for END were fluctuating symptoms (adjusted odds ratio [aOR] = 1.64, assigned 1 point), proximal vertebrobasilar occlusion (aOR = 2.59, assigned 2 points), and Tmax > 6 seconds volumes (aOR = 1.87, assigned 1 point) (all P < 0.001). The predictive scale showed excellent discrimination in the derivation cohort (AUC = 0.921, 95% confidence interval [CI]: 0.882-0.965) and good calibration (Brier score = 0.103). The derivation and validation cohorts were similar in most baseline characteristics. Significant differences were observed in symptom evolution, intravenous thrombolysis usage, and occlusion sites. External validation in an independent cohort yielded an AUC of 0.857 (0.825-0.934) and a Brier score of 0.130.</p><p><strong>Conclusions: </strong>This externally validated scale provided a practical tool to identify high-risk END patients for targeted interventions.</p>","PeriodicalId":23906,"journal":{"name":"World neurosurgery","volume":" ","pages":"124304"},"PeriodicalIF":2.1000,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World neurosurgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.wneu.2025.124304","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: We sought to construct a scoring model to predict early neurological worsening (END) among minor vertebrobasilar occlusive strokes (National Institutes of Health Stroke Scale [NIHSS] score < 6) following best medical management (BMM).

Methods: Between January 2019 and June 2024, 137 patients were recruited from a single center. END was characterized by a ≥ 4-point rise in NIHSS within 72 hours, without intracranial hemorrhage. Logistic regression analysis identified predictors for END, which were used to construct a scale. External validation was performed using a separate cohort from another hospital during the same study period (n=81). Model performance was assessed using receiver operating characteristic (ROC) curve analysis, area under the curve (AUC), calibration plots, and Brier score.

Results: END occurred in 41 patients (29.9%). Independent predictors for END were fluctuating symptoms (adjusted odds ratio [aOR] = 1.64, assigned 1 point), proximal vertebrobasilar occlusion (aOR = 2.59, assigned 2 points), and Tmax > 6 seconds volumes (aOR = 1.87, assigned 1 point) (all P < 0.001). The predictive scale showed excellent discrimination in the derivation cohort (AUC = 0.921, 95% confidence interval [CI]: 0.882-0.965) and good calibration (Brier score = 0.103). The derivation and validation cohorts were similar in most baseline characteristics. Significant differences were observed in symptom evolution, intravenous thrombolysis usage, and occlusion sites. External validation in an independent cohort yielded an AUC of 0.857 (0.825-0.934) and a Brier score of 0.130.

Conclusions: This externally validated scale provided a practical tool to identify high-risk END patients for targeted interventions.

急性轻度椎基底动脉闭塞性卒中早期神经功能恶化的预测工具。
目的:我们试图建立一个评分模型来预测最佳医疗管理(BMM)后轻度椎基底动脉闭塞性卒中(美国国立卫生研究院卒中量表[NIHSS]评分< 6)的早期神经系统恶化(END)。方法:2019年1月至2024年6月,从单个中心招募137名患者。END的特征是72小时内NIHSS升高≥4点,无颅内出血。逻辑回归分析确定了END的预测因子,并用于构建量表。外部验证采用同一研究期间来自另一家医院的单独队列(n=81)。采用受试者工作特征(ROC)曲线分析、曲线下面积(AUC)、校正图和Brier评分来评估模型的性能。结果:END发生41例(29.9%)。END的独立预测因子为波动症状(调整优势比[aOR] = 1.64,分配1分)、近端椎基底动脉闭塞(aOR = 2.59,分配2分)和Tmax > 6秒容量(aOR = 1.87,分配1分)(均P < 0.001)。该预测量表在衍生队列中具有良好的判别性(AUC = 0.921, 95%可信区间[CI]: 0.882-0.965)和良好的校准性(Brier评分= 0.103)。推导组和验证组在大多数基线特征上相似。两组患者在症状演变、静脉溶栓使用、闭塞部位等方面均存在显著差异。在独立队列的外部验证中,AUC为0.857 (0.825-0.934),Brier评分为0.130。结论:这个外部验证的量表提供了一个实用的工具来识别高风险的终末期患者,并进行有针对性的干预。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
World neurosurgery
World neurosurgery CLINICAL NEUROLOGY-SURGERY
CiteScore
3.90
自引率
15.00%
发文量
1765
审稿时长
47 days
期刊介绍: World Neurosurgery has an open access mirror journal World Neurosurgery: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review. The journal''s mission is to: -To provide a first-class international forum and a 2-way conduit for dialogue that is relevant to neurosurgeons and providers who care for neurosurgery patients. The categories of the exchanged information include clinical and basic science, as well as global information that provide social, political, educational, economic, cultural or societal insights and knowledge that are of significance and relevance to worldwide neurosurgery patient care. -To act as a primary intellectual catalyst for the stimulation of creativity, the creation of new knowledge, and the enhancement of quality neurosurgical care worldwide. -To provide a forum for communication that enriches the lives of all neurosurgeons and their colleagues; and, in so doing, enriches the lives of their patients. Topics to be addressed in World Neurosurgery include: EDUCATION, ECONOMICS, RESEARCH, POLITICS, HISTORY, CULTURE, CLINICAL SCIENCE, LABORATORY SCIENCE, TECHNOLOGY, OPERATIVE TECHNIQUES, CLINICAL IMAGES, VIDEOS
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信